Drug Type Small molecule drug |
Synonyms PRO-229 |
Target |
Mechanism mAChRs agonists(Muscarinic acetylcholine receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC9H19NO4 |
InChIKeySNPLKNRPJHDVJA-ZETCQYMHSA-N |
CAS Registry81-13-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 1 | - | 30 May 2024 |